According to LabCorp's latest financial reports the company's total liabilities are $8.83 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $8.83 B | -12% |
2022-12-31 | $10.03 B | -0.72% |
2021-12-31 | $10.11 B | -4.92% |
2020-12-31 | $10.63 B | 1.49% |
2019-12-31 | $10.47 B | 13.73% |
2018-12-31 | $9.21 B | -6.64% |
2017-12-31 | $9.86 B | 12.9% |
2016-12-31 | $8.74 B | -4.57% |
2015-12-31 | $9.15 B | 104.4% |
2014-12-31 | $4.48 B | 0.15% |
2013-12-31 | $4.47 B | 9.74% |
2012-12-31 | $4.07 B | 13.01% |
2011-12-31 | $3.60 B | -2.5% |
2010-12-31 | $3.70 B | 35.48% |
2009-12-31 | $2.73 B | -4.48% |
2008-12-31 | $2.85 B | 8.21% |
2007-12-31 | $2.64 B | 30.6% |
2006-12-31 | $2.02 B | 1.69% |
2005-12-31 | $1.99 B | 22.33% |
2004-12-31 | $1.62 B | 7.1% |
2003-12-31 | $1.51 B | 56.81% |
2002-12-31 | $0.96 B | 14.75% |
2001-12-31 | $0.84 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
IDEXX Laboratories IDXX | $1.77 B | -79.90% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $7.60 B | -13.93% | ๐บ๐ธ USA |
NeoGenomics
NEO | $0.73 B | -91.63% | ๐บ๐ธ USA |
Qiagen QGEN | $2.30 B | -73.88% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | $28.3 M | -99.68% | ๐บ๐ธ USA |